Technical CommentsInfectious Disease

Response to Comment on “A small-molecule antivirulence agent for treating Clostridium difficile infection”

See allHide authors and affiliations

Science Translational Medicine  21 Dec 2016:
Vol. 8, Issue 370, pp. 370tr2
DOI: 10.1126/scitranslmed.aaf3410


Ebselen’s antivirulence activity in Clostridium difficile infection is likely due to multiple modes of action, but the contribution of each to its efficacy remains unclear.

View Full Text

Stay Connected to Science Translational Medicine